ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 66.79

Change

-0.17 (-0.25)%

Market Cap

CAD 0.23B

Volume

725.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-14 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.17 (+0.36%)

CAD 3.50B
ZWU:CA BMO Covered Call Utilities ETF

-0.08 (-0.70%)

CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

-0.11 (-0.14%)

CAD 0.78B
HTA:CA Harvest Tech Achievers Growth ..

-0.05 (-0.26%)

CAD 0.67B
TXF:CA First Asset Tech Giants Covere..

+0.13 (+0.59%)

CAD 0.66B
XHC:CA iShares Global Healthcare (CAD..

-0.83 (-1.20%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.03 (+0.14%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.05 (+0.16%)

CAD 0.40B
CWW:CA iShares Global Water Common Cl..

-0.23 (-0.39%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.51 (+0.79%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.64% 31% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.64% 29% F 48% F
Trailing 12 Months  
Capital Gain -5.44% 17% F 14% F
Dividend Return 0.69% 28% F 8% B-
Total Return -4.75% 6% D- 13% F
Trailing 5 Years  
Capital Gain 6.85% 34% F 45% F
Dividend Return 2.66% 21% F 5% F
Total Return 9.51% 17% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain 3.25% 31% F 44% F
Dividend Return 3.66% 20% F 39% F
Total Return 0.41% 26% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 15.73% 63% D 54% F
Risk Adjusted Return 23.26% 17% F 37% F
Market Capitalization 0.23B 65% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.